International Congress on

Advances in Hematology and Vascular Disorders

THEME: "Advancing Research, Enhancing Patient Outcomes"

img2 15-16 Mar 2027
img2 London, UK

Hemato-oncology therapeutics

Hemato-oncology therapeutics refer to the treatment strategies used to manage cancers of the blood, such as leukemia, lymphoma, and multiple myeloma. These therapies work by targeting abnormal blood cells, stopping their growth, and restoring normal blood formation.


  • Chemotherapy: Drugs that kill rapidly dividing cancer cells.
  • Targeted Therapy: Precision medicines that block specific cancer mutations (e.g., BCR-ABL, FLT3, BTK).
  • Immunotherapy: Treatments that boost or redirect the immune system, including monoclonal antibodies, bispecific antibodies, and checkpoint inhibitors.
  • Cellular Therapy: Advanced therapies like CAR-T cells and stem cell transplantation.
  • Radiation Therapy: Used for local control or conditioning before transplant.
  • Supportive Care: Infection prevention, transfusions, and symptom management.